142 related articles for article (PubMed ID: 6893834)
21. Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells.
Wright JR; Wager RE; Hawgood S; Dobbs L; Clements JA
J Biol Chem; 1987 Feb; 262(6):2888-94. PubMed ID: 3818626
[TBL] [Abstract][Full Text] [Related]
22. An ethanol/ether soluble apoprotein from rat lung surfactant augments liposome uptake by isolated granular pneumocytes.
Claypool WD; Wang DL; Chander A; Fisher AB
J Clin Invest; 1984 Sep; 74(3):677-84. PubMed ID: 6547963
[TBL] [Abstract][Full Text] [Related]
23. Diffuse alveolar damage and acute interstitial pneumonitis: histochemical evaluation with lectins and monoclonal antibodies against surfactant apoprotein and collagen type IV.
Sugiyama K; Kawai T
Mod Pathol; 1993 May; 6(3):242-8. PubMed ID: 8346171
[TBL] [Abstract][Full Text] [Related]
24. Analysis of pulmonary surfactant apoproteins by isoelectric focusing.
Katyal SL; Singh G
Biochim Biophys Acta; 1984 Jul; 794(3):411-8. PubMed ID: 6430347
[TBL] [Abstract][Full Text] [Related]
25. Monitoring alveolar epithelial function in acute lung injury.
Hastings RH
J Clin Monit Comput; 2000; 16(5-6):385-92. PubMed ID: 12580221
[TBL] [Abstract][Full Text] [Related]
26. Surfactant apoprotein A (SP-A) is synthesized in airway cells.
Auten RL; Watkins RH; Shapiro DL; Horowitz S
Am J Respir Cell Mol Biol; 1990 Nov; 3(5):491-6. PubMed ID: 2223103
[TBL] [Abstract][Full Text] [Related]
27. The alveolar type II cells as a model for investigating the metabolism of surfactant phospholipids.
Anceschi MM
Eur Respir J Suppl; 1989 Mar; 3():10s-12s. PubMed ID: 2742680
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of pulmonary surfactant apoprotein A mRNA in alveolar type II cells and nonciliated bronchiolar (Clara) epithelial cells in streptozotocin-induced diabetic rats demonstrated by in situ hybridization.
Sugahara K; Iyama K; Sano K; Morioka T
Am J Respir Cell Mol Biol; 1992 Mar; 6(3):307-14. PubMed ID: 1540394
[TBL] [Abstract][Full Text] [Related]
29. Sclerosing hemangioma of the lung. Immunohistochemical characterization of its origin as related to surfactant apoprotein.
Nagata N; Dairaku M; Ishida T; Sueishi K; Tanaka K
Cancer; 1985 Jan; 55(1):116-23. PubMed ID: 2981138
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells.
Dobbs LG; Wright JR; Hawgood S; Gonzalez R; Venstrom K; Nellenbogen J
Proc Natl Acad Sci U S A; 1987 Feb; 84(4):1010-4. PubMed ID: 3469643
[TBL] [Abstract][Full Text] [Related]
31. Reconstitution of surfactant activity by using the 6 kDa apoprotein associated with pulmonary surfactant.
Yu SH; Possmayer F
Biochem J; 1986 May; 236(1):85-9. PubMed ID: 3098235
[TBL] [Abstract][Full Text] [Related]
32. The exogenous surfactant Curosurf enhances phosphatidylcholine content in isolated type II cells.
Bourbon JR; Chailley-Heu B; Gautier B
Eur Respir J; 1997 Apr; 10(4):914-9. PubMed ID: 9150335
[TBL] [Abstract][Full Text] [Related]
33. Amphipathic alpha-helical peptides based on surfactant apoprotein SP-A.
McLean LR; Lewis JE; Hagaman KA; Owen TJ; Jackson RL
Biochim Biophys Acta; 1993 Feb; 1166(1):31-8. PubMed ID: 8431490
[TBL] [Abstract][Full Text] [Related]
34. Specific binding of surfactant apoprotein SP-A to rat alveolar macrophages.
Pison U; Wright JR; Hawgood S
Am J Physiol; 1992 Apr; 262(4 Pt 1):L412-7. PubMed ID: 1314502
[TBL] [Abstract][Full Text] [Related]
35. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary corpora amylacea contain surfactant apoprotein.
Akino T; Mizumoto M; Shimizu H; Kuroki Y; Dempo K; Tsuda T; Yanai S; Mizuki M
Pathol Res Pract; 1990 Oct; 186(5):687-91; discussion 691-5. PubMed ID: 2287594
[TBL] [Abstract][Full Text] [Related]
37. Sialic acid of lung surfactant apoprotein, SP 28-36, is not required for the Ca2+-mediated interactions between surfactant lipids and SP 28-36.
Efrati H; Hawgood S
Biochim Biophys Acta; 1987 Feb; 917(3):425-7. PubMed ID: 3801512
[TBL] [Abstract][Full Text] [Related]
38. Reconstitution of surfactant activity using purified human apoprotein and phospholipids measured in vitro and in vivo.
Revak SD; Merritt TA; Hallman M; Cochrane CG
Am Rev Respir Dis; 1986 Dec; 134(6):1258-65. PubMed ID: 3789526
[TBL] [Abstract][Full Text] [Related]
39. Insulin inhibits the accumulation of the major lung surfactant apoprotein in human fetal lung explants maintained in vitro.
Snyder JM; Mendelson CR
Endocrinology; 1987 Apr; 120(4):1250-7. PubMed ID: 3549256
[TBL] [Abstract][Full Text] [Related]
40. A common pathway for the uptake of surfactant lipids by alveolar cells.
Poelma DL; Ju MR; Bakker SC; Zimmermann LJ; Lachmann BF; van Iwaarden JF
Am J Respir Cell Mol Biol; 2004 May; 30(5):751-8. PubMed ID: 14644915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
